经颈动脉血运重建联合动态血流逆转与颈动脉内膜剥脱术在血管质量倡议监测项目中的比较
该研究基于VQI TCAR监测项目数据,采用倾向评分匹配比较TCAR与CEA治疗颈动脉狭窄的围术期及1年结局。匹配后每组6384例,两组院内卒中/死亡、卒中及死亡无显著差异,但TCAR组心肌梗死、颅神经损伤及术后高血压发生率更低,住院超过1天比例更低;1年同侧卒中或死亡无显著差异。
要点
- TCAR与CEA围术期卒中/死亡、卒中及死亡风险无显著差异
- TCAR组心肌梗死、颅神经损伤及术后高血压发生率显著低于CEA
- TCAR组住院超过1天比例更低,1年同侧卒中或死亡无差异
核心结论
- TCAR与CEA围术期卒中/死亡风险相当,但TCAR显著降低心肌梗死和颅神经损伤风险,1年同侧卒中或死亡无差异。
研究设计与样本
- 基于美国血管外科学会VQI TCAR监测项目2016-2019年数据的倾向评分匹配分析,匹配后TCAR组和CEA组各6384例。
主要发现
- 院内卒中/死亡TCAR 1.6% vs CEA 1.6%,RR 1.01(95%CI 0.77-1.33),P=0.945。
- 院内卒中TCAR 1.4% vs CEA 1.4%,RR 1.02(95%CI 0.76-1.37),P=0.881。
- 院内死亡TCAR 0.4% vs CEA 0.3%,RR 1.14(95%CI 0.64-2.02),P=0.662。
- 院内心肌梗死TCAR 0.5% vs CEA 0.9%,RR 0.53(95%CI 0.35-0.83),P=0.005。
- 颅神经损伤TCAR 0.4% vs CEA 2.7%,RR 0.14(95%CI 0.08-0.23),P<0.001;术后高血压TCAR 13% vs CEA 18.8%,RR 0.69(95%CI 0.63-0.76),P<0.001;住院超过1天TCAR 26.4% vs CEA 30.1%,RR 0.88(95%CI 0.82-0.94),P<0.001;1年同侧卒中或死亡HR 1.09(95%CI 0.87-1.36),P=0.44。
临床怎么用
- 对于颈动脉狭窄患者,TCAR可作为CEA的替代选择,尤其需关注降低心肌梗死和颅神经损伤风险时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the outcomes of TCAR with flow reversal to the gold standard CEA using data from the Society for Vascular Surgery Vascular Quality Initiative TCAR Surveillance Project. SUMMARY OF BACKGROUND DATA: TCAR is a novel minimally invasive procedure for carotid revascularization in high-risk patients that is associated with significantly lower stroke rates compared with carotid artery stenting via the transfemoral approach. METHODS: Patients in the United States and Canada who underwent TCAR and CEA for carotid artery stenosis (2016-2019) were included. Propensity scores were calculated based on baseline clinical variables and used to match patients in the 2 treatment groups (n = 6384 each). The primary endpoint was the combined outcome of perioperative stroke and/or death. RESULTS: No significant differences were observed between TCAR and CEA in terms of in-hospital stroke/death [TCAR, 1.6% vs CEA, 1.6%, RR (95% CI): 1.01 (0.77-1.33), P = 0.945], stroke [1.4% vs 1.4%, RR (95% CI): 1.02 (0.76-1.37), P = 0.881], or death [0.4% vs 0.3%, RR (95% CI): 1.14 (0.64-2.02), P = 0.662]. Compared to CEA, TCAR was associated with lower rates of in-hospital myocardial infarction [0.5% vs 0.9%, RR (95% CI): 0.53 (0.35-0.83), P = 0.005], cranial nerve injury [0.4% vs 2.7%, RR (95% CI): 0.14 (0.08-0.23), P < 0.001], and post-procedural hypertension [13% vs 18.8%, RR (95% CI): 0.69 (0.63-0.76), P < 0.001]. They were also less likely to stay in the hospital for more than 1 day [26.4% vs 30.1%, RR (95% CI): 0.88 (0.82-0.94), P < 0.001]. No significant interaction was observed between procedure and symptomatic status in predicting postoperative outcomes. At 1 year, the incidence of ipsilateral stroke or death was similar between the 2 groups [HR (95% CI): 1.09 (0.87-1.36), P = 0.44]. CONCLUSIONS: This propensity-score matched analysis demonstrated significant reduction in the risk of postoperative myocardial infarction and cranial nerve injury after TCAR compared to CEA, with no differences in the rates of stroke/death.
引用
- Malas MB, Dakour-Aridi H, Kashyap VS, et al. TransCarotid Revascularization With Dynamic Flow Reversal Versus Carotid Endarterectomy in the Vascular Quality Initiative Surveillance Project. Ann Surg. 2020. PMID: 32941280. doi:10.1097/SLA.0000000000004496
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。